Abstract:Level IB metastasis is relatively rare in nasopharyngeal carcinoma (NPC). However, many institutions recommend electively irradiation to level IB to level V in NPC, which covers the submandibular glands (SMG) in the target volume and is associated with deterioration of xerostomia. The purpose of this study is to investigate the high-risk factors for level IB metastasis in NPC and evaluate the feasibility of selectively omission of radiation to level IB in the low-risk subgroups. This retrospective study identified 532 patients with non-metastatic NPC treated by intensity modulated radiation therapy (IMRT) in our institution from 2009 to 2010. Level IB nodes were electively included in the clinical target volume based on the attending physician’s decision. At that time, the SMG dose was not constrained during inverse treatment planning. Late xerostomia was scored according to CTCAE 3.0 system. Diagnostic head and neck MRIs were retrospectively reviewed and the involvement of nodal levels was evaluated according to RTOG guidelines. The correlation of level IB metastasis and other imaging factors were studied using Chi-square test and logistic regression model. Log-rank test was used to compare survival rates. Cox proportional-hazards models were used to evaluate the effect of various factors on survival. Univariate analysis showed that advanced N stage, bilateral nodal metastasis, level IIA involvement, the maximal axial diameter (MAD) of level IIA nodes >20 mm, necrosis or extracapsular spread of level IIA correlated with level IB metastasis at diagnosis. In multivariate analysis (MVA), bilateral nodal involvement, MAD of level IIA nodes >20 mm or extracapsular spread of level IIA nodes, were independent predictive factors of level IB metastasis at diagnosis. Patients without either of these factors were denoted low-risk subgroup and the rest high-risk subgroup. With a median follow-up of 51.5 (1.0-74.7) months, the 5-year estimated regional control and overall survival (OS) was 94.4% and 84.8%, respectively. Of the low-risk subgroup, there was no significant difference of regional control and OS between those with or without elective irradiation to level IB. The percentage of level IB recurrence of those without elective irradiation was only 0.46%. Elective level IB irradiation was not significant upon MVA both for regional control and OS. Of the high-risk subgroup, elective level IB irradiation was marginal significant for regional control, but not for OS upon MVA. Overall, elective irradiation of level IB increased the mean doses of SMGs, but did not transfer into reduction of late xerostomia. Our study demonstrated the MAD of level IIA nodes > 20 mm and/or level IIA nodes with extracapsular spread, positive bilateral cervical lymph nodes were independent risk factor for level IB metastasis in NPC. For patients without either of these factors, selectively omission of irradiation to level IB did not impair regional control and OS.

A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model

The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline

The Feasibility of Selectively Omission of Radiation to Level IB Lymph Nodes in Low-Risk Nasopharyngeal Carcinoma

Risk Factors of Level Ib Lymph Node Metastasis and Clinical Outcome of Its Selectively Prophylactic Irradiation in Nasopharyngeal Carcinoma: A Real-World Study

The Feasibility Analysis of Omission of Elective Irradiation to Level IB Lymph Nodes in Low-Risk Nasopharyngeal Carcinoma Based on the 2013 Updated Consensus Guideline for Neck Nodal Levels

Risk Factors and Distribution Features of Level IB Lymph Nodes Metastasis in Nasopharyngeal Carcinoma.

Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study

Rationality of the international guideline’s recommendation regarding selective coverage of level Ib in clinical target volume with nasopharyngeal carcinoma: Results from a real-world series

Investigation of the Feasibility of Elective Irradiation to Neck Level Ib Using Intensity-Modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma: a Retrospective Analysis

Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline

Prophylactic Irradiation at the Level Ib for Nasopharyngeal Carcinoma: Should That Be a Routine?

Sparing Level Ib Lymph Nodes by Intensity-Modulated Radiotherapy in the Treatment of Nasopharyngeal Carcinoma

Influence of Level-Ib Lymphadenopathy on Prognosis of Nasopharyngeal Carcinoma

Comparative Study on Prophylactic Irradiation to the Whole Neck and to the Upper Neck for Patients with Neck Lymph Node-Negative Nasopharyngeal Carcinoma.

Volume of prophylactic irradiation to neck for stage N0 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era

Prophylactic irradiation of cervical lymph nodes for Stage-NO nasopharyngeal carcinoma

A Risk Score Model for the Metastasis of Level Ib Lymph Node Based on the Clinicopathological Features of Nasopharyngeal Carcinoma in a Large Sample.

The Feasibility of Omitting Irradiation to the Contralateral Lower Neck in Stage N1 Nasopharyngeal Carcinoma Patients

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy

Application of risk category system to evaluate the treatment outcome of locoregionally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy alone